Do analysts recommend ADXS or QNRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ayala Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is ADXS or QNRX more profitable?

Ayala Pharmaceuticals' return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Ayala Pharmaceuticals N/A N/A N/A Quoin Pharmaceuticals N/A -489.57% -221.17%

Do analysts rate QNRX or PYRGF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate QNRX or MIRA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 MIRA Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, QNRX or MIRA?

MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quoin Pharmaceuticals N/A N/A -$15.81M -$25.18 N/A MIRA Pharmaceuticals N/A N/A -$10.44M -$1.24 N/A

Is QNRX or MIRA more profitable?

MIRA Pharmaceuticals' return on equity of -106.95% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Quoin Pharmaceuticals N/A -489.57% -221.17% MIRA Pharmaceuticals N/A -106.95% -104.18%

Do analysts rate UG or QNRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score United-Guardian 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer GLMD or QNRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galmed Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Quoin Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, GLMD or QNRX?

Galmed Pharmaceuticals is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Galmed Pharmaceuticals N/A N/A -$10.31M -$7.28 N/A Quoin Pharmaceuticals N/A N/A -$15.81M -$25.18 N/A

Is GLMD or QNRX more profitable?

Galmed Pharmaceuticals' return on equity of -35.32% beat Quoin Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Galmed Pharmaceuticals N/A -35.32% -30.94% Quoin Pharmaceuticals N/A -489.57% -221.17%

Quoin Pharmaceuticals (QNRX) Competitors

$5.42 -0.15 (-2.69%)

Closing price 08/24/2026 04:00 PM Eastern

Extended Trading

$5.44 +0.01 (+0.28%)

As of 08/24/2026 04:10 PM Eastern

Compare

QNRX vs. ADXS, PYRGF, MIRA, UG, and GLMD

Should you buy Quoin Pharmaceuticals stock or one of its competitors? Quoin Pharmaceuticals's main competitors and comparable companies include Ayala Pharmaceuticals (ADXS), PyroGenesis Canada (PYRGF), MIRA Pharmaceuticals (MIRA), United-Guardian (UG), and Galmed Pharmaceuticals (GLMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Quoin Pharmaceuticals compare to Ayala Pharmaceuticals?

Ayala Pharmaceuticals (NASDAQ:ADXS) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Ayala Pharmaceuticals has a beta of 1.75, suggesting that its stock price is 75% more volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

Ayala Pharmaceuticals' return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ayala Pharmaceuticals	N/A	N/A	N/A
Quoin Pharmaceuticals	N/A	-489.57%	-221.17%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ayala Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

7.2% of Ayala Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. 0.6% of Ayala Pharmaceuticals shares are owned by insiders. Comparatively, 11.2% of Quoin Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Ayala Pharmaceuticals' average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Ayala Pharmaceuticals	Neutral
Quoin Pharmaceuticals	Neutral

Quoin Pharmaceuticals has lower revenue, but higher earnings than Ayala Pharmaceuticals. Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than Ayala Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ayala Pharmaceuticals	$3.24M	11.05	-$48.07M	-$5.02	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$25.18	N/A

Summary

Ayala Pharmaceuticals beats Quoin Pharmaceuticals on 6 of the 11 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to PyroGenesis Canada?

Quoin Pharmaceuticals (NASDAQ:QNRX) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

Quoin Pharmaceuticals has higher earnings, but lower revenue than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$25.18	N/A
PyroGenesis Canada	$9.14M	3.74	-$21.12M	-$0.04	N/A

Quoin Pharmaceuticals has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market. Comparatively, PyroGenesis Canada has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market.

In the previous week, PyroGenesis Canada had 3 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for PyroGenesis Canada and 0 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled PyroGenesis Canada'saverage media sentiment score.

Company	Overall Sentiment
Quoin Pharmaceuticals	Neutral
PyroGenesis Canada	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 11.2% of Quoin Pharmaceuticals shares are held by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Quoin Pharmaceuticals has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.57%	-221.17%
PyroGenesis Canada	-115.14%	N/A	-60.81%

Summary

Quoin Pharmaceuticals beats PyroGenesis Canada on 7 of the 13 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to MIRA Pharmaceuticals?

Quoin Pharmaceuticals (NASDAQ:QNRX) and MIRA Pharmaceuticals (NASDAQ:MIRA) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

MIRA Pharmaceuticals' return on equity of -106.95% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quoin Pharmaceuticals	N/A	-489.57%	-221.17%
MIRA Pharmaceuticals	N/A	-106.95%	-104.18%

Quoin Pharmaceuticals has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, MIRA Pharmaceuticals has a beta of 1.54, indicating that its share price is 54% more volatile than the broader market.

8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. 11.2% of Quoin Pharmaceuticals shares are held by company insiders. Comparatively, 19.9% of MIRA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Quoin Pharmaceuticals' average media sentiment score of 0.00 equaled MIRA Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Quoin Pharmaceuticals	Neutral
MIRA Pharmaceuticals	Neutral

MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$25.18	N/A
MIRA Pharmaceuticals	N/A	N/A	-$10.44M	-$1.24	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
MIRA Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

MIRA Pharmaceuticals beats Quoin Pharmaceuticals on 7 of the 8 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to United-Guardian?

United-Guardian (NASDAQ:UG) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United-Guardian	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

United-Guardian has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market.

United-Guardian has a net margin of 22.01% compared to Quoin Pharmaceuticals' net margin of 0.00%. United-Guardian's return on equity of 22.24% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
United-Guardian	22.01%	22.24%	19.12%
Quoin Pharmaceuticals	N/A	-489.57%	-221.17%

United-Guardian has higher revenue and earnings than Quoin Pharmaceuticals. Quoin Pharmaceuticals is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United-Guardian	$10.55M	3.11	$2.11M	$0.54	13.22
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$25.18	N/A

In the previous week, United-Guardian's average media sentiment score of 0.00 equaled Quoin Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
United-Guardian	Neutral
Quoin Pharmaceuticals	Neutral

23.2% of United-Guardian shares are held by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. 29.0% of United-Guardian shares are held by insiders. Comparatively, 11.2% of Quoin Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

United-Guardian beats Quoin Pharmaceuticals on 9 of the 11 factors compared between the two stocks.

How does Quoin Pharmaceuticals compare to Galmed Pharmaceuticals?

Galmed Pharmaceuticals (NASDAQ:GLMD) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Galmed Pharmaceuticals is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Galmed Pharmaceuticals	N/A	N/A	-$10.31M	-$7.28	N/A
Quoin Pharmaceuticals	N/A	N/A	-$15.81M	-$25.18	N/A

Galmed Pharmaceuticals' return on equity of -35.32% beat Quoin Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Galmed Pharmaceuticals	N/A	-35.32%	-30.94%
Quoin Pharmaceuticals	N/A	-489.57%	-221.17%

In the previous week, Galmed Pharmaceuticals had 4 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 4 mentions for Galmed Pharmaceuticals and 0 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 0.00 beat Galmed Pharmaceuticals' score of -0.14 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Galmed Pharmaceuticals	Neutral
Quoin Pharmaceuticals	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Galmed Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Quoin Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Galmed Pharmaceuticals has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, Quoin Pharmaceuticals has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market.

76.1% of Galmed Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. 19.8% of Galmed Pharmaceuticals shares are owned by company insiders. Comparatively, 11.2% of Quoin Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Galmed Pharmaceuticals beats Quoin Pharmaceuticals on 7 of the 12 factors compared between the two stocks.

Get Quoin Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QNRX vs. The Competition

Export

Metric	Quoin Pharmaceuticals	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$11.19M	$12.54B	$7.36B	$12.81B
Dividend Yield	N/A	2.61%	2.54%	10.78%
P/E Ratio	-0.22	780.42	270.56	24.05
Price / Sales	N/A	758.20	639.68	105.23
Price / Cash	N/A	15.47	29.03	36.89
Price / Book	0.35	10.42	11.18	6.40
Net Income	-$15.81M	$2.79B	$3.46B	$347.95M
7 Day Performance	9.05%	1.80%	1.73%	1.49%
1 Month Performance	26.64%	4.70%	7.33%	5.15%
1 Year Performance	-26.76%	7.66%	26.11%	17.01%

Quoin Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QNRX Quoin Pharmaceuticals	0.542 of 5 stars	$5.42 -2.7%	N/A	-25.5%	$11.19M	N/A	N/A	4	Gap Down
ADXS Ayala Pharmaceuticals	N/A	$0.60 flat	N/A	N/A	$35.79M	$3.24M	N/A	20
PYRGF PyroGenesis Canada	N/A	$0.15 -0.2%	N/A	-32.5%	$33.71M	$9.14M	N/A	90	News Coverage Gap Down
MIRA MIRA Pharmaceuticals	1.0083 of 5 stars	$0.78 +2.0%	N/A	-44.9%	$32.78M	N/A	N/A	2	Gap Up
UG United-Guardian	1.8042 of 5 stars	$7.05 -0.3%	N/A	-13.3%	$32.36M	$10.55M	13.06	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QNRX) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quoin Pharmaceuticals (QNRX) Competitors

QNRX vs. ADXS, PYRGF, MIRA, UG, and GLMD

How does Quoin Pharmaceuticals compare to Ayala Pharmaceuticals?

Summary

How does Quoin Pharmaceuticals compare to PyroGenesis Canada?

Summary

How does Quoin Pharmaceuticals compare to MIRA Pharmaceuticals?

Summary

How does Quoin Pharmaceuticals compare to United-Guardian?

Summary

How does Quoin Pharmaceuticals compare to Galmed Pharmaceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QNRX vs. The Competition

Quoin Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quoin Pharmaceuticals (QNRX) Competitors

QNRX vs. ADXS, PYRGF, MIRA, UG, and GLMD

How does Quoin Pharmaceuticals compare to Ayala Pharmaceuticals?

Which has more risk and volatility, ADXS or QNRX?

Is ADXS or QNRX more profitable?

Do analysts recommend ADXS or QNRX?

Do institutionals & insiders have more ownership in ADXS or QNRX?

Does the media favor ADXS or QNRX?

Which has preferable valuation & earnings, ADXS or QNRX?

Summary

How does Quoin Pharmaceuticals compare to PyroGenesis Canada?

Which has preferable valuation and earnings, QNRX or PYRGF?

Which has more risk & volatility, QNRX or PYRGF?

Does the media refer more to QNRX or PYRGF?

Do analysts rate QNRX or PYRGF?

Do insiders & institutionals hold more shares of QNRX or PYRGF?

Is QNRX or PYRGF more profitable?

Summary

How does Quoin Pharmaceuticals compare to MIRA Pharmaceuticals?

Is QNRX or MIRA more profitable?

Which has more volatility and risk, QNRX or MIRA?

Do institutionals and insiders have more ownership in QNRX or MIRA?

Does the media prefer QNRX or MIRA?

Which has better valuation and earnings, QNRX or MIRA?

Do analysts rate QNRX or MIRA?

Summary

How does Quoin Pharmaceuticals compare to United-Guardian?

Do analysts rate UG or QNRX?

Which has more risk and volatility, UG or QNRX?

Is UG or QNRX more profitable?

Which has preferable valuation and earnings, UG or QNRX?

Does the media favor UG or QNRX?

Do insiders and institutionals believe in UG or QNRX?

Summary

How does Quoin Pharmaceuticals compare to Galmed Pharmaceuticals?

Which has stronger valuation & earnings, GLMD or QNRX?

Is GLMD or QNRX more profitable?

Does the media prefer GLMD or QNRX?

Do analysts prefer GLMD or QNRX?

Which has more volatility & risk, GLMD or QNRX?

Do insiders and institutionals have more ownership in GLMD or QNRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QNRX vs. The Competition

Quoin Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools